All-cause and cause-specific mortality during and following incarceration in Brazil: A retrospective cohort study.


Journal

PLoS medicine
ISSN: 1549-1676
Titre abrégé: PLoS Med
Pays: United States
ID NLM: 101231360

Informations de publication

Date de publication:
09 2021
Historique:
received: 24 05 2021
accepted: 01 09 2021
revised: 01 10 2021
pubmed: 18 9 2021
medline: 1 12 2021
entrez: 17 9 2021
Statut: epublish

Résumé

Mortality during and after incarceration is poorly understood in low- and middle-income countries (LMICs). The need to address this knowledge gap is especially urgent in South America, which has the fastest growing prison population in the world. In Brazil, insufficient data have precluded our understanding of all-cause and cause-specific mortality during and after incarceration. We linked incarceration and mortality databases for the Brazilian state of Mato Grosso do Sul to obtain a retrospective cohort of 114,751 individuals with recent incarceration. Between January 1, 2009 and December 31, 2018, we identified 3,127 deaths of individuals with recent incarceration (705 in detention and 2,422 following release). We analyzed age-standardized, all-cause, and cause-specific mortality rates among individuals detained in different facility types and following release, compared to non-incarcerated residents. We additionally modeled mortality rates over time during and after incarceration for all causes of death, violence, or suicide. Deaths in custody were 2.2 times the number reported by the national prison administration (n = 317). Incarcerated men and boys experienced elevated mortality, compared with the non-incarcerated population, due to increased risk of death from violence, suicide, and communicable diseases, with the highest standardized incidence rate ratio (IRR) in semi-open prisons (2.4; 95% confidence interval [CI]: 2.0 to 2.8), police stations (3.1; 95% CI: 2.5 to 3.9), and youth detention (8.1; 95% CI: 5.9 to 10.8). Incarcerated women experienced increased mortality from suicide (IRR = 6.0, 95% CI: 1.2 to 17.7) and communicable diseases (IRR = 2.5, 95% CI: 1.1 to 5.0). Following release from prison, mortality was markedly elevated for men (IRR = 3.0; 95% CI: 2.8 to 3.1) and women (IRR = 2.4; 95% CI: 2.1 to 2.9). The risk of violent death and suicide was highest immediately post-release and declined over time; however, all-cause mortality remained elevated 8 years post-release. The limitations of this study include inability to establish causality, uncertain reliability of data during incarceration, and underestimation of mortality rates due to imperfect database linkage. Incarcerated individuals in Brazil experienced increased mortality from violence, suicide, and communicable diseases. Mortality was heightened following release for all leading causes of death, with particularly high risk of early violent death and elevated all-cause mortality up to 8 years post-release. These disparities may have been underrecognized in Brazil due to underreporting and insufficient data.

Sections du résumé

BACKGROUND
Mortality during and after incarceration is poorly understood in low- and middle-income countries (LMICs). The need to address this knowledge gap is especially urgent in South America, which has the fastest growing prison population in the world. In Brazil, insufficient data have precluded our understanding of all-cause and cause-specific mortality during and after incarceration.
METHODS AND FINDINGS
We linked incarceration and mortality databases for the Brazilian state of Mato Grosso do Sul to obtain a retrospective cohort of 114,751 individuals with recent incarceration. Between January 1, 2009 and December 31, 2018, we identified 3,127 deaths of individuals with recent incarceration (705 in detention and 2,422 following release). We analyzed age-standardized, all-cause, and cause-specific mortality rates among individuals detained in different facility types and following release, compared to non-incarcerated residents. We additionally modeled mortality rates over time during and after incarceration for all causes of death, violence, or suicide. Deaths in custody were 2.2 times the number reported by the national prison administration (n = 317). Incarcerated men and boys experienced elevated mortality, compared with the non-incarcerated population, due to increased risk of death from violence, suicide, and communicable diseases, with the highest standardized incidence rate ratio (IRR) in semi-open prisons (2.4; 95% confidence interval [CI]: 2.0 to 2.8), police stations (3.1; 95% CI: 2.5 to 3.9), and youth detention (8.1; 95% CI: 5.9 to 10.8). Incarcerated women experienced increased mortality from suicide (IRR = 6.0, 95% CI: 1.2 to 17.7) and communicable diseases (IRR = 2.5, 95% CI: 1.1 to 5.0). Following release from prison, mortality was markedly elevated for men (IRR = 3.0; 95% CI: 2.8 to 3.1) and women (IRR = 2.4; 95% CI: 2.1 to 2.9). The risk of violent death and suicide was highest immediately post-release and declined over time; however, all-cause mortality remained elevated 8 years post-release. The limitations of this study include inability to establish causality, uncertain reliability of data during incarceration, and underestimation of mortality rates due to imperfect database linkage.
CONCLUSIONS
Incarcerated individuals in Brazil experienced increased mortality from violence, suicide, and communicable diseases. Mortality was heightened following release for all leading causes of death, with particularly high risk of early violent death and elevated all-cause mortality up to 8 years post-release. These disparities may have been underrecognized in Brazil due to underreporting and insufficient data.

Identifiants

pubmed: 34534214
doi: 10.1371/journal.pmed.1003789
pii: PMEDICINE-D-21-02293
pmc: PMC8486113
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1003789

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI130058
Pays : United States

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

BMJ Open. 2019 May 5;9(5):e026853
pubmed: 31061044
Int J Epidemiol. 2007 Apr;36(2):310-6
pubmed: 17158524
Demography. 2010 Aug;47(3):587-607
pubmed: 20879679
Aggress Violent Behav. 2013 Sep;18(5):471-483
pubmed: 24027422
Br Med Bull. 2018 Mar 1;125(1):15-23
pubmed: 29394343
Ann Epidemiol. 2011 Oct;21(10):719-26
pubmed: 21737304
Addiction. 2010 Sep;105(9):1545-54
pubmed: 20579009
Public Health Rep. 2019 Nov/Dec;134(6):660-666
pubmed: 31603737
PLoS Med. 2019 Jan 24;16(1):e1002737
pubmed: 30677013
Soc Sci Res. 2014 Jul;46:142-54
pubmed: 24767596
Int J Law Psychiatry. 2012 May-Jun;35(3):222-30
pubmed: 22445577
SSM Popul Health. 2016 Jan 06;2:10-13
pubmed: 29349123
Eur J Public Health. 2006 Aug;16(4):441-4
pubmed: 16431869
Emerg Infect Dis. 2017 Mar;23(3):496-499
pubmed: 28221118
J Health Soc Behav. 2008 Mar;49(1):56-71
pubmed: 18418985
Am J Public Health. 2008 Dec;98(12):2278-84
pubmed: 18923131
Cien Saude Colet. 2020 Feb;25(2):623-632
pubmed: 32022202
Lancet. 2016 Sep 10;388(10049):1089-1102
pubmed: 27427453
N Engl J Med. 2007 Jan 11;356(2):157-65
pubmed: 17215533
PLoS One. 2014 Feb 14;9(2):e88836
pubmed: 24551174
Am J Public Health. 2012 Dec;102(12):e67-75
pubmed: 23078476
Am J Epidemiol. 2012 Mar 15;175(6):519-26
pubmed: 22331462
Addiction. 2013 Jan;108(1):38-49
pubmed: 23163705
Popul Health Metr. 2010 May 10;8:9
pubmed: 20459720
Arch Intern Med. 2009 Apr 13;169(7):687-93
pubmed: 19364998
Rev Esp Salud Publica. 2011 Jun;85(3):245-55
pubmed: 21892549
Soc Psychiatry Psychiatr Epidemiol. 2021 Feb;56(2):315-323
pubmed: 32405788
Lancet Psychiatry. 2017 Dec;4(12):946-952
pubmed: 29179937
Med J Aust. 2007 Oct 1;187(7):387-90
pubmed: 17908000
Am J Epidemiol. 2011 Mar 1;173(5):479-87
pubmed: 21239522

Auteurs

Yiran E Liu (YE)

Department of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford, California, United States of America.
Cancer Biology Graduate Program, Stanford University School of Medicine, Stanford, California, United States of America.

Everton Ferreira Lemos (EF)

School of Medicine, Federal University of Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil.

Crhistinne Cavalheiro Maymone Gonçalves (CCM)

School of Medicine, Federal University of Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil.

Roberto Dias de Oliveira (RD)

State University of Mato Grosso do Sul, Dourados, Mato Grosso do Sul, Brazil.

Andrea da Silva Santos (ADS)

Faculty of Health Sciences, Federal University of Grande Dourados, Dourados, Mato Grosso do Sul, Brazil.

Agne Oliveira do Prado Morais (AO)

School of Medicine, Federal University of Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil.

Mariana Garcia Croda (MG)

School of Medicine, Federal University of Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil.

Maria de Lourdes Delgado Alves (M)

Division of Prison Health Assistance, Agência Estadual de Administração do Sistema Penitenciário, Campo Grande, Mato Grosso do Sul, Brazil.

Julio Croda (J)

School of Medicine, Federal University of Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil.
Oswaldo Cruz Foundation, Campo Grande, Mato Grosso do Sul, Brazil.
Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut, United States of America.

Katharine S Walter (KS)

Department of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford, California, United States of America.

Jason R Andrews (JR)

Department of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford, California, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH